Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden

Fertility and Sterility

Volumn 91, Issue 4, 2009, Pages 1152-1158

  Sanner, Karin ^a,d   Conner, Peter ^b   Bergfeldt, Kjell ^a,b   Dickman, Paul ^a   Sundfeldt, Karin ^c   Bergh, Torbjörn ^d   Hagenfeldt, Kerstin ^b   Janson, Per Olof ^c   Nilsson, Staffan ^e   Persson, Ingemar ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^e Department of Obstetrics   (Sweden)

Author keywords

historical cohort; hormonal infertility treatment; Ovarian neoplasia risk; ovulatory disorders

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; GONADOTROPIN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; INFERTILITY; LONG TERM CARE; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY INSUFFICIENCY; OVARY TUMOR; PRIORITY JOURNAL; SWEDEN; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; COHORT STUDIES; FEMALE; FERTILITY AGENTS, FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFERTILITY, FEMALE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; SWEDEN; YOUNG ADULT;

EID: 62949182311     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.01.073     Document Type: Article

References (20)

1. Guppy A.E., Nathan P.D., and Rustin G.J. Epithelial ovarian cancer: a review of current management. Clin Oncol (R Coll Radiol) 17 (2005) 399-411
2. FIGO (International Federation of Gynecology and Obstetrics) annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 83 Suppl 1 (2003) ix-xxii, 1-229
3. Rossing M.A., Daling J.R., Weiss N.S., Moore D.E., and Self S.G. Ovarian tumors in a cohort of infertile women. N Engl J Med 331 (1994) 771-776
4. U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. Ann Intern Med (2005) 355-361
5. Adami H.O., Hsieh C.C., Lambe M., Trichopoulos D., Leon D., Persson I., et al. Parity, age at first childbirth, and risk of ovarian cancer. Lancet 344 (1994) 1250-1254
6. Mahdavi A., Pejovic T., and Nezhat F. Induction of ovulation and ovarian cancer: a critical review of the literature. Fertil Steril 85 (2006) 819-826
7. Whittemore A.S., Harris R., and Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol 136 (1992) 1212-1220
8. Harris R., Whittemore A.S., and Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136 (1992) 1204-1211
9. Brinton L.A., Lamb E.J., Moghissi K.S., Scoccia B., Althuis M.D., Mabie J.E., et al. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol 103 (2004) 1194-1203
10. Gemzell C.A., Diczfalusy E., and Tillinger G. Clinical effect of human pituitary follicle-stimulating hormone (FSH). J Clin Endocrinol Metab 18 (1958) 1333-1348
11. Gemzell C. Induction of ovulation. Acta Obstet Gynecol Scand Suppl 47 (1975) 1-5
12. Fishman J., and Brown J.B. Quantitation of urinary estrogens by gas chromatography. J Chromatogr 8 (1962) 21-24
13. Nillius S.J. Therapeutic use of luteinizing hormone-releasing hormone in the human female. Curr Top Mol Endocrinol 3 (1976) 93-112
14. The National Board of Health and Welfare. The Swedish Hospital Discharge Register 1998-2004 (2006), The Centre for Epidemiology, Stockholm, Sweden
15. The National Board of Health and Welfare. The Swedish Registry of Cancer Incidence 1958-2004 (2005), The Centre for Epidemiology, Stockholm, Sweden
16. Colombo N., Parma G., Zanagnolo V., and Insinga A. Management of ovarian stromal cell tumors. J Clin Oncol 25 (2007) 2944-2951
17. Ness R.B., Cramer D.W., Goodman M.T., Kjaer S.K., Mallin K., Mosgaard B.J., et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 155 (2002) 217-224
18. Venn A., Watson L., Bruinsma F., Giles G., and Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354 (1999) 1586-1590
19. Shushan A., Paltiel O., Iscovich J., Elchalal U., Peretz T., and Schenker J.G. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 65 (1996) 13-18
20. Mosgaard B.J., Lidegaard O., Kjaer S.K., Schou G., and Andersen A.N. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 67 (1997) 1005-1012